Capula Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-23,256
Closed -$937K 644
2024
Q2
$937K Buy
+23,256
New +$970K 0.01% 157
2021
Q4
Sell
-1,870
Closed -$223K 738
2021
Q3
$223K Sell
1,870
-7,356
-80% -$810K ﹤0.01% 776
2021
Q2
$899K Buy
+9,226
New +$823K 0.01% 378

Other funds holding TNDM

Capula Management's TNDM Position: Q3 2024 in Review

Capula Management sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 23,256 shares — an estimated $937K sold.

Capula Management first reported a position in TNDM in Q2 2021 and held it in 3 quarters. The position peaked at $937K in Q2 2024. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • Capula Management reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
  • Capula Management sold 23,256 Tandem Diabetes Care shares in Q3 2024, an estimated $937K.
  • Capula Management first reported a position in Tandem Diabetes Care in Q2 2021 and held it in 3 quarters.
  • Capula Management's Tandem Diabetes Care position peaked at $937K in Q2 2024.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Capula Management's 13F filing for Q3 2024, filed 13 Nov 2024.